{"protocolSection": {"identificationModule": {"nctId": "NCT04343872", "orgStudyIdInfo": {"id": "IRB-300005012"}, "secondaryIdInfos": [{"id": "3P30DK079626-12S1", "type": "NIH", "link": "https://reporter.nih.gov/quickSearch/3P30DK079626-12S1"}], "organization": {"fullName": "University of Alabama at Birmingham", "class": "OTHER"}, "briefTitle": "Preventing Diabetes in the Deep South: Extending Partnerships and Adapting Interventions to Reach Rural Communities at High Risk.", "officialTitle": "UAB Diabetes Research Center (DRC): Chronic Disease and the Reduction of Health Disparities Supplement"}, "statusModule": {"statusVerifiedDate": "2024-02", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2020-12-10", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2022-12-31", "type": "ACTUAL"}, "completionDateStruct": {"date": "2022-12-31", "type": "ACTUAL"}, "studyFirstSubmitDate": "2020-04-07", "studyFirstSubmitQcDate": "2020-04-07", "studyFirstPostDateStruct": {"date": "2020-04-13", "type": "ACTUAL"}, "resultsFirstSubmitDate": "2024-01-01", "resultsFirstSubmitQcDate": "2024-02-06", "resultsFirstPostDateStruct": {"date": "2024-03-05", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2024-02-06", "lastUpdatePostDateStruct": {"date": "2024-03-05", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "PRINCIPAL_INVESTIGATOR", "investigatorFullName": "Andrea Cherrington, MD", "investigatorTitle": "Professor", "investigatorAffiliation": "University of Alabama at Birmingham"}, "leadSponsor": {"name": "University of Alabama at Birmingham", "class": "OTHER"}, "collaborators": [{"name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)", "class": "NIH"}]}, "oversightModule": {"oversightHasDmc": false, "isFdaRegulatedDrug": false, "isFdaRegulatedDevice": false}, "descriptionModule": {"briefSummary": "Diabetes is responsible for a huge and growing burden of patient suffering and social costs, and the impact of this disease is shared disproportionately by minorities and in rural resource-challenged communities, particularly in the Deep South. To address this problem, the University of Alabama (UAB) Diabetes Research Center (DRC) will establish a primary care clinical network in rural counties of Alabama and in the Mississippi delta that will provide the (DRC) and its members with opportunities for partnership and the infrastructure to conduct translational and clinical research in those patients with the greatest need. A pilot trial will be conducted within the coalition to assess feasibility for a larger trial to evaluate a novel and sustainable approach for diabetes prevention that involves an innovative lifestyle intervention combined with metformin.", "detailedDescription": "The pilot trial in aim three will include enrolling four primary care practices. Each of the participating practices will be randomized to one of two arms and accordingly enrolled participants from each clinic will be assigned to one of two conditions:\n\nCondition 1. Receive lifestyle modification alone (Diabetes Prevention Program (DPP).\n\nCondition 2. Receive lifestyle modification (DPP) with metformin therapy recommendation.\n\nTwenty five participants will be enrolled from each participating practice. Participants will be followed up for 12-14 months after recruitment."}, "conditionsModule": {"conditions": ["Pre-diabetes"], "keywords": ["Obesity", "Metformin Therapy"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "FACTORIAL", "primaryPurpose": "PREVENTION", "maskingInfo": {"masking": "SINGLE", "whoMasked": ["OUTCOMES_ASSESSOR"]}}, "enrollmentInfo": {"count": 36, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Receive lifestyle modification alone (DPP)", "type": "ACTIVE_COMPARATOR", "description": "Participants in this arm will receive a lifestyle modification intervention program facilitated by Peer Coach (PC) services", "interventionNames": ["Behavioral: Receive lifestyle modification alone"]}, {"label": "Receive lifestyle modification with metformin therapy", "type": "EXPERIMENTAL", "description": "Participants in this arm will receive a lifestyle modification intervention program facilitated by Peer Coach (PC) services plus metformin recommendation", "interventionNames": ["Behavioral: Receive lifestyle modification alone", "Behavioral: Metformin therapy"]}], "interventions": [{"type": "BEHAVIORAL", "name": "Receive lifestyle modification alone", "description": "Participants will receive a 12-month lifestyle intervention program (telehealth + peer coach). The intervention comprises of the Center for Disease Control and Prevention (CDC)-adapted DPP Prevent Type 2 (PreventT2) lifestyle intervention program consisting of 26 classes delivered by trained health educators via telehealth. Additionally, the peer coach provides ongoing support over 12-months with tapered calls mirroring ongoing classes. Participants are randomized at the practice level. Two clinics will be randomized to receive the lifestyle intervention program alone.", "armGroupLabels": ["Receive lifestyle modification alone (DPP)", "Receive lifestyle modification with metformin therapy"]}, {"type": "BEHAVIORAL", "name": "Metformin therapy", "description": "The two other clinics will be randomized to receive the lifestyle intervention program (described above) with METFORMIN therapy recommendations. Participants are randomized at the practice level. The primary care provider at the clinic will prescribe metformin and participants would be encouraged to take it if the primary care provider consider prescribing.", "armGroupLabels": ["Receive lifestyle modification with metformin therapy"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Change in Body Weight", "description": "Change in body weight from baseline to 12-months", "timeFrame": "12 months"}, {"measure": "Change in Glycosylated Hemoglobin (HbA1c)", "description": "Change in glycosylated hemoglobin (HbA1c) point of care test values", "timeFrame": "12 months"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Age 19 to 65 years\n* Body mass index (BMI) \u226530\n* Receives care at one of the participating primary care clinics\n* HbA1c 6.0% to 6.4%\n* Resides in one location at least 5 days each week\n* Willing to attend group-based classes\n* Willing to work with a peer advisor in-person and over the phone\n* Has regular access to telephone or cellular phone\n* Willing and able to use telemonitoring body weight to conduct daily self-weighing\n* Estimated Glomerular Filtration Rate (eGFR) of \u226560 in their medical record within 6 months\n\nExclusion Criteria:\n\n* Diabetes diagnosis or HbA1c \\>6.4% or fasting glucose \u2265126\n* HbA1c \\<6.0%\n* Pregnancy or anticipating pregnancy\n* Unwilling or unable to do any of the following: give informed consent, accept random assignment, allow study staff to visit them at their primary care clinic for two follow-up visits\n* Likely to relocate within next 6 months and no longer be seen at clinic within the next 12 months\n* Weight loss \u22655% of body weight in past 6 months (other than postpartum)\n* Past bariatric surgery\n* Prescription weight loss medications within the past 6 months\n* eGFR \\< 60 within past 6 months\n* Unable to ambulate\n* Have end-stage medical conditions with limited life expectancy", "healthyVolunteers": true, "sex": "ALL", "minimumAge": "19 Years", "maximumAge": "65 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Andrea Cherrington, MD, MPH", "affiliation": "University of Alabama at Birmingham", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "UAB", "city": "Birmingham", "state": "Alabama", "zip": "35205", "country": "United States", "geoPoint": {"lat": 33.52066, "lon": -86.80249}}]}, "ipdSharingStatementModule": {"ipdSharing": "NO"}}, "resultsSection": {"participantFlowModule": {"typeUnitsAnalyzed": "Clinic", "groups": [{"id": "FG000", "title": "Receive Lifestyle Modification Alone (DPP)", "description": "Participants in this arm will receive a lifestyle modification intervention program facilitated by Peer Coach (PC) services\n\nReceive lifestyle modification alone: Participants will receive a 12-month lifestyle intervention program (telehealth + peer coach). The intervention comprises of the Center for Disease Control and Prevention (CDC)-adapted DPP Prevent Type 2 (PreventT2) lifestyle intervention program consisting of 26 classes delivered by trained health educators via telehealth. Additionally, the peer coach provides ongoing support over 12-months with tapered calls mirroring ongoing classes. Participants are randomized at the practice level. Two clinics will be randomized to receive the lifestyle intervention program alone."}, {"id": "FG001", "title": "Receive Lifestyle Modification With Metformin Therapy", "description": "Participants in this arm will receive a lifestyle modification intervention program facilitated by Peer Coach (PC) services plus metformin recommendation\n\nReceive lifestyle modification alone: Participants will receive a 12-month lifestyle intervention program (telehealth + peer coach). The intervention comprises of the Center for Disease Control and Prevention (CDC)-adapted DPP Prevent Type 2 (PreventT2) lifestyle intervention program consisting of 26 classes delivered by trained health educators via telehealth. Additionally, the peer coach provides ongoing support over 12-months with tapered calls mirroring ongoing classes. Participants are randomized at the practice level. Two clinics will be randomized to receive the lifestyle intervention program alone.\n\nMetformin therapy: The two other clinics will be randomized to receive the lifestyle intervention program (described above) with METFORMIN therapy recommendations. Participants are randomized at the practice level. The primary care provider at the clinic will prescribe metformin and participants would be encouraged to take it if the primary care provider consider prescribing."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "29", "numUnits": "2"}, {"groupId": "FG001", "numSubjects": "7", "numUnits": "2"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "23", "numUnits": "2"}, {"groupId": "FG001", "numSubjects": "4", "numUnits": "2"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "6", "numUnits": "0"}, {"groupId": "FG001", "numSubjects": "3", "numUnits": "0"}]}], "dropWithdraws": [{"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "6"}, {"groupId": "FG001", "numSubjects": "3"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Receive Lifestyle Modification Alone (DPP)", "description": "Participants in this arm will receive a lifestyle modification intervention program facilitated by Peer Coach (PC) services\n\nReceive lifestyle modification alone: Participants will receive a 12-month lifestyle intervention program (telehealth + peer coach). The intervention comprises of the Center for Disease Control and Prevention (CDC)-adapted DPP Prevent Type 2 (PreventT2) lifestyle intervention program consisting of 26 classes delivered by trained health educators via telehealth. Additionally, the peer coach provides ongoing support over 12-months with tapered calls mirroring ongoing classes. Participants are randomized at the practice level. Two clinics will be randomized to receive the lifestyle intervention program alone."}, {"id": "BG001", "title": "Receive Lifestyle Modification With Metformin Therapy", "description": "Participants in this arm will receive a lifestyle modification intervention program facilitated by Peer Coach (PC) services plus metformin recommendation\n\nReceive lifestyle modification alone: Participants will receive a 12-month lifestyle intervention program (telehealth + peer coach). The intervention comprises of the Center for Disease Control and Prevention (CDC)-adapted DPP Prevent Type 2 (PreventT2) lifestyle intervention program consisting of 26 classes delivered by trained health educators via telehealth. Additionally, the peer coach provides ongoing support over 12-months with tapered calls mirroring ongoing classes. Participants are randomized at the practice level. Two clinics will be randomized to receive the lifestyle intervention program alone.\n\nMetformin therapy: The two other clinics will be randomized to receive the lifestyle intervention program (described above) with METFORMIN therapy recommendations. Participants are randomized at the practice level. The primary care provider at the clinic will prescribe metformin and participants would be encouraged to take it if the primary care provider consider prescribing."}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "29"}, {"groupId": "BG001", "value": "7"}, {"groupId": "BG002", "value": "36"}]}], "measures": [{"title": "Age, Categorical", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "<=18 years", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Between 18 and 65 years", "measurements": [{"groupId": "BG000", "value": "29"}, {"groupId": "BG001", "value": "7"}, {"groupId": "BG002", "value": "36"}]}, {"title": ">=65 years", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}]}]}, {"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "Years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "49.7", "spread": "10.3"}, {"groupId": "BG001", "value": "47.0", "spread": "12.3"}, {"groupId": "BG002", "value": "49.2", "spread": "10.7"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "24"}, {"groupId": "BG001", "value": "6"}, {"groupId": "BG002", "value": "30"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "5"}, {"groupId": "BG001", "value": "1"}, {"groupId": "BG002", "value": "6"}]}]}]}, {"title": "Race (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "American Indian or Alaska Native", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Asian", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Native Hawaiian or Other Pacific Islander", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Black or African American", "measurements": [{"groupId": "BG000", "value": "20"}, {"groupId": "BG001", "value": "5"}, {"groupId": "BG002", "value": "25"}]}, {"title": "White", "measurements": [{"groupId": "BG000", "value": "9"}, {"groupId": "BG001", "value": "2"}, {"groupId": "BG002", "value": "11"}]}, {"title": "More than one race", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "United States", "categories": [{"measurements": [{"groupId": "BG000", "value": "29"}, {"groupId": "BG001", "value": "7"}, {"groupId": "BG002", "value": "36"}]}]}]}, {"title": "Body Weight", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "pounds", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "264.4", "spread": "44.78"}, {"groupId": "BG001", "value": "251.9", "spread": "69.07"}, {"groupId": "BG002", "value": "258.3", "spread": "57.27"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Change in Body Weight", "description": "Change in body weight from baseline to 12-months", "populationDescription": "Participants lost to follow-up", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Pounds", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "Receive Lifestyle Modification Alone (DPP)", "description": "Participants in this arm will receive a lifestyle modification intervention program facilitated by Peer Coach (PC) services\n\nReceive lifestyle modification alone: Participants will receive a 12-month lifestyle intervention program (telehealth + peer coach). The intervention comprises of the Center for Disease Control and Prevention (CDC)-adapted DPP Prevent Type 2 (PreventT2) lifestyle intervention program consisting of 26 classes delivered by trained health educators via telehealth. Additionally, the peer coach provides ongoing support over 12-months with tapered calls mirroring ongoing classes. Participants are randomized at the practice level. Two clinics will be randomized to receive the lifestyle intervention program alone."}, {"id": "OG001", "title": "Receive Lifestyle Modification With Metformin Therapy", "description": "Participants in this arm will receive a lifestyle modification intervention program facilitated by Peer Coach (PC) services plus metformin recommendation\n\nReceive lifestyle modification alone: Participants will receive a 12-month lifestyle intervention program (telehealth + peer coach). The intervention comprises of the Center for Disease Control and Prevention (CDC)-adapted DPP Prevent Type 2 (PreventT2) lifestyle intervention program consisting of 26 classes delivered by trained health educators via telehealth. Additionally, the peer coach provides ongoing support over 12-months with tapered calls mirroring ongoing classes. Participants are randomized at the practice level. Two clinics will be randomized to receive the lifestyle intervention program alone.\n\nMetformin therapy: The two other clinics will be randomized to receive the lifestyle intervention program (described above) with METFORMIN therapy recommendations. Participants are randomized at the practice level. The primary care provider at the clinic will prescribe metformin and participants would be encouraged to take it if the primary care provider consider prescribing."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "23"}, {"groupId": "OG001", "value": "4"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-3.6", "spread": "11.87"}, {"groupId": "OG001", "value": "-4.4", "spread": "3.21"}]}]}]}, {"type": "PRIMARY", "title": "Change in Glycosylated Hemoglobin (HbA1c)", "description": "Change in glycosylated hemoglobin (HbA1c) point of care test values", "populationDescription": "Participants lost to follow-up", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Percentage of glycosylated hemoglobin", "timeFrame": "12 months", "groups": [{"id": "OG000", "title": "Receive Lifestyle Modification Alone (DPP)", "description": "Participants in this arm will receive a lifestyle modification intervention program facilitated by Peer Coach (PC) services\n\nReceive lifestyle modification alone: Participants will receive a 12-month lifestyle intervention program (telehealth + peer coach). The intervention comprises of the Center for Disease Control and Prevention (CDC)-adapted DPP Prevent Type 2 (PreventT2) lifestyle intervention program consisting of 26 classes delivered by trained health educators via telehealth. Additionally, the peer coach provides ongoing support over 12-months with tapered calls mirroring ongoing classes. Participants are randomized at the practice level. Two clinics will be randomized to receive the lifestyle intervention program alone."}, {"id": "OG001", "title": "Receive Lifestyle Modification With Metformin Therapy", "description": "Participants in this arm will receive a lifestyle modification intervention program facilitated by Peer Coach (PC) services plus metformin recommendation\n\nReceive lifestyle modification alone: Participants will receive a 12-month lifestyle intervention program (telehealth + peer coach). The intervention comprises of the Center for Disease Control and Prevention (CDC)-adapted DPP Prevent Type 2 (PreventT2) lifestyle intervention program consisting of 26 classes delivered by trained health educators via telehealth. Additionally, the peer coach provides ongoing support over 12-months with tapered calls mirroring ongoing classes. Participants are randomized at the practice level. Two clinics will be randomized to receive the lifestyle intervention program alone.\n\nMetformin therapy: The two other clinics will be randomized to receive the lifestyle intervention program (described above) with METFORMIN therapy recommendations. Participants are randomized at the practice level. The primary care provider at the clinic will prescribe metformin and participants would be encouraged to take it if the primary care provider consider prescribing."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "23"}, {"groupId": "OG001", "value": "4"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-0.1", "spread": "0.52"}, {"groupId": "OG001", "value": "-0.5", "spread": "0.99"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "12-months", "eventGroups": [{"id": "EG000", "title": "Receive Lifestyle Modification Alone (DPP)", "description": "Participants in this arm will receive a lifestyle modification intervention program facilitated by Peer Coach (PC) services\n\nReceive lifestyle modification alone: Participants will receive a 12-month lifestyle intervention program (telehealth + peer coach). The intervention comprises of the Center for Disease Control and Prevention (CDC)-adapted DPP Prevent Type 2 (PreventT2) lifestyle intervention program consisting of 26 classes delivered by trained health educators via telehealth. Additionally, the peer coach provides ongoing support over 12-months with tapered calls mirroring ongoing classes. Participants are randomized at the practice level. Two clinics will be randomized to receive the lifestyle intervention program alone.", "deathsNumAffected": 0, "deathsNumAtRisk": 29, "seriousNumAffected": 0, "seriousNumAtRisk": 29, "otherNumAffected": 0, "otherNumAtRisk": 29}, {"id": "EG001", "title": "Receive Lifestyle Modification With Metformin Therapy", "description": "Participants in this arm will receive a lifestyle modification intervention program facilitated by Peer Coach (PC) services plus metformin recommendation\n\nReceive lifestyle modification alone: Participants will receive a 12-month lifestyle intervention program (telehealth + peer coach). The intervention comprises of the Center for Disease Control and Prevention (CDC)-adapted DPP Prevent Type 2 (PreventT2) lifestyle intervention program consisting of 26 classes delivered by trained health educators via telehealth. Additionally, the peer coach provides ongoing support over 12-months with tapered calls mirroring ongoing classes. Participants are randomized at the practice level. Two clinics will be randomized to receive the lifestyle intervention program alone.\n\nMetformin therapy: The two other clinics will be randomized to receive the lifestyle intervention program (described above) with METFORMIN therapy recommendations. Participants are randomized at the practice level. The primary care provider at the clinic will prescribe metformin and participants would be encouraged to take it if the primary care provider consider prescribing.", "deathsNumAffected": 0, "deathsNumAtRisk": 7, "seriousNumAffected": 0, "seriousNumAtRisk": 7, "otherNumAffected": 0, "otherNumAtRisk": 7}]}, "moreInfoModule": {"limitationsAndCaveats": {"description": "COVID-19 greatly impacted ability to recruit participants and retain participants."}, "certainAgreement": {"piSponsorEmployee": false, "restrictiveAgreement": false}, "pointOfContact": {"title": "Dr. Andrea L. Cherrington", "organization": "University of Alabama at Birmingham", "email": "acherrington@uabmc.edu", "phone": "205-996-2885"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "Prot_SAP", "hasProtocol": true, "hasSap": true, "hasIcf": false, "label": "Study Protocol and Statistical Analysis Plan", "date": "2021-09-27", "uploadDate": "2023-12-27T18:11", "filename": "Prot_SAP_000.pdf", "size": 546974}, {"typeAbbrev": "ICF", "hasProtocol": false, "hasSap": false, "hasIcf": true, "label": "Informed Consent Form", "date": "2020-12-17", "uploadDate": "2023-12-27T18:24", "filename": "ICF_001.pdf", "size": 193618}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000003920", "term": "Diabetes Mellitus"}, {"id": "D000011236", "term": "Prediabetic State"}], "ancestors": [{"id": "D000044882", "term": "Glucose Metabolism Disorders"}, {"id": "D000008659", "term": "Metabolic Diseases"}, {"id": "D000004700", "term": "Endocrine System Diseases"}], "browseLeaves": [{"id": "M7115", "name": "Diabetes Mellitus", "asFound": "Diabetes", "relevance": "HIGH"}, {"id": "M14117", "name": "Prediabetic State", "asFound": "Pre-diabetes", "relevance": "HIGH"}, {"id": "M12701", "name": "Obesity", "relevance": "LOW"}, {"id": "M6147", "name": "Chronic Disease", "relevance": "LOW"}, {"id": "M20295", "name": "Glucose Intolerance", "relevance": "LOW"}, {"id": "M11639", "name": "Metabolic Diseases", "relevance": "LOW"}, {"id": "M25403", "name": "Glucose Metabolism Disorders", "relevance": "LOW"}, {"id": "M7862", "name": "Endocrine System Diseases", "relevance": "LOW"}, {"id": "T1303", "name": "Chronic Graft Versus Host Disease", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC18", "name": "Nutritional and Metabolic Diseases"}, {"abbrev": "BC19", "name": "Gland and Hormone Related Diseases"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC23", "name": "Symptoms and General Pathology"}, {"abbrev": "Rare", "name": "Rare Diseases"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000008687", "term": "Metformin"}], "ancestors": [{"id": "D000007004", "term": "Hypoglycemic Agents"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}], "browseLeaves": [{"id": "M11667", "name": "Metformin", "asFound": "Assessment", "relevance": "HIGH"}, {"id": "M10054", "name": "Hypoglycemic Agents", "relevance": "LOW"}], "browseBranches": [{"abbrev": "Hypo", "name": "Hypoglycemic Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}]}}, "hasResults": true}